CN105806966B - 一种用于高光学纯度叶酸制备过程的质量控制方法 - Google Patents
一种用于高光学纯度叶酸制备过程的质量控制方法 Download PDFInfo
- Publication number
- CN105806966B CN105806966B CN201410844213.2A CN201410844213A CN105806966B CN 105806966 B CN105806966 B CN 105806966B CN 201410844213 A CN201410844213 A CN 201410844213A CN 105806966 B CN105806966 B CN 105806966B
- Authority
- CN
- China
- Prior art keywords
- folic acid
- optical
- acid
- purity
- quality control
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 title claims abstract description 182
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 title claims abstract description 91
- 229960000304 folic acid Drugs 0.000 title claims abstract description 91
- 235000019152 folic acid Nutrition 0.000 title claims abstract description 91
- 239000011724 folic acid Substances 0.000 title claims abstract description 91
- 238000000034 method Methods 0.000 title claims abstract description 42
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- 238000003908 quality control method Methods 0.000 title claims abstract description 17
- 230000003287 optical effect Effects 0.000 claims abstract description 60
- 239000012071 phase Substances 0.000 claims description 20
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 11
- 239000002253 acid Substances 0.000 claims description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 7
- 238000001514 detection method Methods 0.000 claims description 7
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 6
- 238000005342 ion exchange Methods 0.000 claims description 5
- 239000007791 liquid phase Substances 0.000 claims description 5
- LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 claims description 4
- 239000003513 alkali Substances 0.000 claims description 4
- 238000010828 elution Methods 0.000 claims description 4
- 239000002585 base Substances 0.000 claims description 3
- 238000005070 sampling Methods 0.000 claims description 3
- AVBGNFCMKJOFIN-UHFFFAOYSA-N triethylammonium acetate Chemical compound CC(O)=O.CCN(CC)CC AVBGNFCMKJOFIN-UHFFFAOYSA-N 0.000 claims description 3
- 235000001258 Cinchona calisaya Nutrition 0.000 claims description 2
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 claims description 2
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 claims description 2
- 239000000945 filler Substances 0.000 claims description 2
- 229960000948 quinine Drugs 0.000 claims description 2
- -1 tert-butylamino methyl Chemical class 0.000 claims description 2
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims 6
- 239000000203 mixture Substances 0.000 claims 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 2
- 229960000583 acetic acid Drugs 0.000 claims 2
- 150000003983 crown ethers Chemical class 0.000 claims 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims 2
- 238000003821 enantio-separation Methods 0.000 claims 2
- 239000012362 glacial acetic acid Substances 0.000 claims 2
- 150000004676 glycans Chemical class 0.000 claims 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 claims 2
- 229920001282 polysaccharide Polymers 0.000 claims 2
- 239000005017 polysaccharide Substances 0.000 claims 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 claims 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims 1
- 239000000654 additive Substances 0.000 claims 1
- 235000019253 formic acid Nutrition 0.000 claims 1
- 229910052698 phosphorus Inorganic materials 0.000 claims 1
- 239000011574 phosphorus Substances 0.000 claims 1
- 235000019260 propionic acid Nutrition 0.000 claims 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 claims 1
- 239000002994 raw material Substances 0.000 abstract description 6
- 229940079593 drug Drugs 0.000 abstract description 4
- 239000003814 drug Substances 0.000 abstract description 4
- 230000035945 sensitivity Effects 0.000 abstract description 4
- 238000005516 engineering process Methods 0.000 abstract description 3
- 238000005220 pharmaceutical analysis Methods 0.000 abstract description 2
- 238000007086 side reaction Methods 0.000 abstract description 2
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 53
- 238000012360 testing method Methods 0.000 description 26
- 239000007788 liquid Substances 0.000 description 13
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 12
- 150000002224 folic acids Chemical class 0.000 description 8
- 239000002243 precursor Substances 0.000 description 7
- 239000012490 blank solution Substances 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 5
- UKJLNMAFNRKWGR-UHFFFAOYSA-N cyclohexatrienamine Chemical group NC1=CC=C=C[CH]1 UKJLNMAFNRKWGR-UHFFFAOYSA-N 0.000 description 5
- 230000007774 longterm Effects 0.000 description 4
- 238000010606 normalization Methods 0.000 description 4
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- SMZHKGXSEAGRTI-UHFFFAOYSA-N 1,1,1-trichloropropan-2-one Chemical compound CC(=O)C(Cl)(Cl)Cl SMZHKGXSEAGRTI-UHFFFAOYSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000010812 external standard method Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000002699 Digestive System Neoplasms Diseases 0.000 description 1
- 208000001164 Osteoporotic Fractures Diseases 0.000 description 1
- 238000009874 alkali refining Methods 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000879 anti-atherosclerotic effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- UEHUZQKLOWYOMO-UHFFFAOYSA-N diethylazanium;acetate Chemical compound CC(O)=O.CCNCC UEHUZQKLOWYOMO-UHFFFAOYSA-N 0.000 description 1
- SULORKHFCYQSPZ-UHFFFAOYSA-N diethylazanium;perchlorate Chemical compound CCNCC.OCl(=O)(=O)=O SULORKHFCYQSPZ-UHFFFAOYSA-N 0.000 description 1
- 208000024558 digestive system cancer Diseases 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 125000003929 folic acid group Chemical group 0.000 description 1
- 201000010231 gastrointestinal system cancer Diseases 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000010829 isocratic elution Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000003032 molecular docking Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 108010048734 sclerotin Proteins 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 125000006318 tert-butyl amino group Chemical group [H]N(*)C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
批次 | 对氨基苯甲酰-L-谷氨酸光学纯度 | 叶酸光学纯度 | 相关性 |
120501 | 99.97% | 99.97% | 良好 |
120502 | 99.96% | 99.96% | 良好 |
120503 | 99.98% | 99.98% | 良好 |
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410844213.2A CN105806966B (zh) | 2014-12-30 | 2014-12-30 | 一种用于高光学纯度叶酸制备过程的质量控制方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410844213.2A CN105806966B (zh) | 2014-12-30 | 2014-12-30 | 一种用于高光学纯度叶酸制备过程的质量控制方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105806966A CN105806966A (zh) | 2016-07-27 |
CN105806966B true CN105806966B (zh) | 2018-03-27 |
Family
ID=56420052
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410844213.2A Active CN105806966B (zh) | 2014-12-30 | 2014-12-30 | 一种用于高光学纯度叶酸制备过程的质量控制方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105806966B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108774230A (zh) * | 2018-07-06 | 2018-11-09 | 南通市常海食品添加剂有限公司 | 一种叶酸的纯化方法 |
CN112649524B (zh) * | 2020-12-02 | 2022-05-17 | 重庆华邦胜凯制药有限公司 | 分离检测叶酸中叶酸及叶酸光学异构体的方法 |
CN113063889A (zh) * | 2021-03-12 | 2021-07-02 | 北京斯利安药业有限公司 | 一种叶酸对映异构体含量的检测方法 |
CN114002352B (zh) * | 2021-10-29 | 2023-01-24 | 四川汇宇制药股份有限公司 | 叶酸与其光学异构体的分离检测方法 |
CN115078613A (zh) * | 2022-05-26 | 2022-09-20 | 河北冀衡药业股份有限公司 | 一种叶酸及其杂质d-叶酸的hplc检测方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102012408A (zh) * | 2010-10-28 | 2011-04-13 | 上海师范大学 | 液相色谱分析n-对氨基苯甲酰-l-谷氨酸纯度的方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH696628A5 (de) * | 2002-02-26 | 2007-08-31 | Eprova Ag | Verwendung von Folaten zur Herstellung einer Zubereitung geeignet zur Vorbeugung und Behandlung von Entzündungen und entzündungsassoziierter Krankheiten, im Speziellen zur Beeinflussung der |
-
2014
- 2014-12-30 CN CN201410844213.2A patent/CN105806966B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102012408A (zh) * | 2010-10-28 | 2011-04-13 | 上海师范大学 | 液相色谱分析n-对氨基苯甲酰-l-谷氨酸纯度的方法 |
Non-Patent Citations (5)
Title |
---|
Capillary zone electrophoresis of oligosaccharides derivatized with N-(4-aminobenzoyl)-c-glutamic acid for ultraviolet absorbance detection;Jiri Plocek 等;《Journal of Chromatography A》;19970103;第757卷(第1-2期);第215-223页 * |
High performance liquid chromatographic determination of folic acid and its photodegradation products in the presence of riboflavin;M. Jamil Akhtar 等;《Journal of Pharmaceutical and Biomedical Analysis》;19970930;第16卷(第1期);第95-99页 * |
Resolution of (±)-βMethylphenylethylamine by a Novel Chiral Stationary Phase for Pirkle-Type Column Chromatography;HAYRULLAH YILMAZ 等;《CHIRALITY》;20100228;第22卷(第2期);第252-257页 * |
催化加氢合成对氨基苯甲酰谷氨酸新工艺;袁杰 等;《化工生产与技术》;20041231;第11卷(第4期);第20-21页 * |
反相高效液相色谱法测定叶酸及其相关物质;刘树彬 等;《分析实验室》;20041130;第23卷(第11期);第33-35页 * |
Also Published As
Publication number | Publication date |
---|---|
CN105806966A (zh) | 2016-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105806966B (zh) | 一种用于高光学纯度叶酸制备过程的质量控制方法 | |
CN104655751B (zh) | 一种检测达泊西汀中有机溶剂残留的方法 | |
CN104020241A (zh) | 动物血、脑样品中痕量烟碱及其主要代谢物的同步分析方法 | |
CN104597160A (zh) | 一种同时测定半夏中6种有机酸含量的hplc方法 | |
CN102072942A (zh) | 一种离子对色谱法测定吡咯并喹呤醌含量的分析方法 | |
CN104749269A (zh) | 一种利用hplc测定阿格列汀原料药及制剂中对映异构体杂质的方法 | |
CN104965041A (zh) | 一种帕瑞昔布钠异构体的高效液相色谱检测方法 | |
CN101502616B (zh) | 白及药材的含量测定方法 | |
CN103698424B (zh) | 一种测定难溶性铝盐药物中有机溶剂的检测方法 | |
CN106018611A (zh) | 一种气相色谱内标法检测中链甘油三酯含量的测定方法 | |
CN104678001A (zh) | 一种用液相色谱法分离测定枸橼酸托法替尼及其光学异构体的方法 | |
Gatti et al. | 1, 4-Anthraquinone: A new useful pre-column reagent for the determination of N-acetylcysteine and captopril in pharmaceuticals by high performance liquid chromatography | |
CN110478313B (zh) | 一种卡络磺钠注射液 | |
CN110441426A (zh) | 一种甲磺酸达比加群酯的检测方法 | |
CN103645251A (zh) | 一种复方阿胶制剂的指纹图谱检测方法 | |
CN113702514A (zh) | 一种阿托伐他汀钙有关杂质ⅰ的测定方法 | |
CN109991334A (zh) | 一种测定血浆中洛索洛芬及其反式羟基体浓度的方法 | |
CN108828122A (zh) | 一种茶氨酸的高效液相检测方法 | |
CN105004803A (zh) | 一种分离测定托伐普坦中多个杂质的液相色谱方法 | |
CN111812240B (zh) | 一种缩宫素及三种杂质的分离方法和应用 | |
CN105572240A (zh) | 一种采用高效液相色谱法检测药用辅料胭脂红含量的方法 | |
CN106290600B (zh) | 一种用液相色谱法分离康尼替尼及有关物质的方法 | |
CN112684031B (zh) | 聚维酮k30含量的hplc测定方法 | |
CN106442765A (zh) | 一种盐酸右美托咪定粗品中异构体的检测方法 | |
CN102680622A (zh) | 一种富马酸卢帕他定含量的液相色谱检测方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Quality control method for high optical purity folic acid preparation process Effective date of registration: 20200325 Granted publication date: 20180327 Pledgee: Beijing Yizhuang International Financing Guarantee Co.,Ltd. Pledgor: BEIJING SILIAN PHARMACEUTICAL INDUSTRY Co.,Ltd. Registration number: Y2020980000995 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20210316 Granted publication date: 20180327 Pledgee: Beijing Yizhuang International Financing Guarantee Co.,Ltd. Pledgor: BEIJING SILIAN PHARMACEUTICAL INDUSTRY Co.,Ltd. Registration number: Y2020980000995 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A quality control method for the preparation of folic acid with high optical purity Effective date of registration: 20210316 Granted publication date: 20180327 Pledgee: Beijing Yizhuang International Financing Guarantee Co.,Ltd. Pledgor: BEIJING SILIAN PHARMACEUTICAL INDUSTRY Co.,Ltd. Registration number: Y2021990000235 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20220309 Granted publication date: 20180327 Pledgee: Beijing Yizhuang International Financing Guarantee Co.,Ltd. Pledgor: BEIJING SILIAN PHARMACEUTICAL INDUSTRY Co.,Ltd. Registration number: Y2021990000235 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A quality control method for the preparation process of high optical purity folic acid Effective date of registration: 20220309 Granted publication date: 20180327 Pledgee: Beijing Yizhuang International Financing Guarantee Co.,Ltd. Pledgor: BEIJING SILIAN PHARMACEUTICAL INDUSTRY Co.,Ltd. Registration number: Y2022990000138 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230330 Granted publication date: 20180327 Pledgee: Beijing Yizhuang International Financing Guarantee Co.,Ltd. Pledgor: BEIJING SILIAN PHARMACEUTICAL INDUSTRY Co.,Ltd. Registration number: Y2022990000138 |